Trexquant Investment LP - NEKTAR THERAPEUTICS ownership

NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 184 filers reported holding NEKTAR THERAPEUTICS in Q2 2015. The put-call ratio across all filers is 0.83 and the average weighting 0.1%.

Quarter-by-quarter ownership
Trexquant Investment LP ownership history of NEKTAR THERAPEUTICS
ValueSharesWeighting
Q3 2020$594,000
-56.5%
35,818
-39.3%
0.04%
-60.0%
Q2 2020$1,366,000
+11.5%
58,971
-14.1%
0.10%
+6.7%
Q1 2020$1,225,000
+103.2%
68,651
+145.7%
0.09%
+147.2%
Q4 2019$603,000
-85.7%
27,936
-59.7%
0.04%
-88.7%
Q3 2018$4,227,000
+15.6%
69,340
-7.4%
0.32%
+25.7%
Q2 2018$3,658,000
+878.1%
74,911
+2028.8%
0.25%
+873.1%
Q1 2018$374,000
-72.1%
3,519
-93.8%
0.03%
-84.9%
Q1 2017$1,340,000
+100.3%
57,092
+4.7%
0.17%
+62.3%
Q4 2016$669,000
+68.5%
54,535
+135.9%
0.11%
+19.1%
Q3 2016$397,000
+12.8%
23,120
-6.6%
0.09%
+93.5%
Q2 2016$352,000
+20.1%
24,763
+42.3%
0.05%
+76.9%
Q4 2015$293,000
+29.6%
17,400
-15.7%
0.03%
+36.8%
Q3 2015$226,000
-27.1%
20,631
-16.8%
0.02%
-45.7%
Q2 2015$310,000
-67.4%
24,800
-71.3%
0.04%
-63.9%
Q1 2015$950,000
+153.3%
86,400
+257.0%
0.10%
+47.0%
Q4 2014$375,00024,2000.07%
Other shareholders
NEKTAR THERAPEUTICS shareholders Q2 2015
NameSharesValueWeighting ↓
Camber Capital Management LP 2,000,000$67,200,0003.35%
First Light Asset Management, LLC 763,403$25,650,0003.33%
BRIDGER MANAGEMENT, LLC 1,238,489$41,613,0003.29%
Rhenman & Partners Asset Management AB 734,445$24,677,0002.89%
BB BIOTECH AG 2,020,676$67,895,0001.71%
Gs Investments, Inc. 54,200$1,821,120,0001.43%
Artal Group S.A. 900,000$30,240,0001.24%
Cormorant Asset Management, LP 500,000$16,800,0001.14%
TOBAM 640,547$21,522,0001.09%
Bellevue Group AG 430,026$14,449,0000.80%
View complete list of NEKTAR THERAPEUTICS shareholders